A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its blockbuster molecule tirzepatide. Now, with a pipeline chock-full of numerous ...

Initiation of incretin receptor agonists (IRAs) is associated with lower continuous positive airway pressure (CPAP) use, hospitalization, and mortality among adults with obesity, type 2 diabetes, and ...

Studies have shown that bariatric surgery can raise the risk of alcohol use disorder (AUD) and other addictive behaviors, a phenomenon often described as "addiction transfer." Treatment with ...

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care. Their qualitative study, "Understanding ...